Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mammary gland epithelial cells form the bilayered structure of the mammary ducts and alveoli, consisting of an inner luminal layer responsible for milk secretion and an outer basal/myoepithelial layer that provides contractile support for milk ejection. These cells drive ductal elongation, branching morphogenesis, and alveolar development during puberty, pregnancy, and lactation through interactions with hormones like estrogen, progesterone, prolactin, and signaling pathways including Wnt/β-catenin, FGF, and PTHrP. They respond to stromal cues from adipocytes, fibroblasts, and extracellular matrix to regulate proliferation, differentiation, porosity. In disease, particularly breast cancer, these cells undergo epithelial-to-mesenchymal transition, losing tumor-suppressive functions of myoepithelial cells, which normally inhibit invasion by maintaining basement membrane integrity. While not direct therapeutic targets like receptors or enzymes, their dysregulation contributes to oncogenesis, with luminal progenitors implicated in tumor initiation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mammary gland epithelial cell.